Bevacizumab to treat complicated liver v
β
Elisabetta Buscarini; Guido Manfredi; Alessandro Zambelli
π
Article
π
2008
π
John Wiley and Sons
π
English
β 45 KB
We read with interest the article by Mitchell et al. 1 dealing with bevacizumab treatment of a patient with hereditary hemorrhagic telangiectasia (HHT), cardiac failure, and portal hypertension due to severe liver vascular malformations (VMs). The treatment reversed the need for liver transplantatio